Closed · PAR-06-358 · CFDA 93.847 · Discretionary
Planning Grants For Translational Research For The Prevention And Control Of Diabetes And Obesity (R34)
Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.
- up to $150K
- Award range
- Closed
- Status
- May 7, 2009
- Close date
- -
- Expected awards
The verdict
Planning Grants For Translational Research For The Prevention And Control Of Diabetes And Obesity (R34) is a closed discretionary listing from National Institutes of Health that offered Up to $150,000. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 12,419 other opportunities from National Institutes of Health.
- up to $150K
- award range
- Closed
- application status
- 93.847
- CFDA program
- 12,419
- other opportunities from National Institutes of Health
Archived opportunity record
Planning Grants For Translational Research Fo… is closed (last close May 7, 2009). The parent program page for CFDA 93.847 is the reliable place to catch re-announcements. National Institutes of Health still indexes 12,419 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed May 7, 2009
Instrument
Grant
Description
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) seeks to develop cost effective and sustainable interventions, that can be adopted in real world settings, for the prevention and control of diabetes and obesity. Research should be based on interventions already proven efficacious in clinical trials to prevent and reverse obesity and type 2 diabetes, to improve care of type 1 and type 2 diabetes and to prevent or delay its complications. The interventions proposed under this solicitation should have the potential to be widely disseminated to clinical practice, individuals and communities at risk.-This FOA invites research applications for planning grants or pilot studies for translational/dissemination research leading to full scale research in diabetes prevention and control as described in the program announcement, PA-02-153-Relevant topics include 1) methods to improve health care delivery to patients with or at risk of diabetes, 2) to enhance diabetes self management, 3) methods to develop strategies to promote healthy lifestyles to reduce the risk of diabetes, 4) methods to promote lifestyle change that will prevent or reverse overweight and obesity, and 5) new cost effective ways to identify people with pre-diabetes and undiagnosed diabetes.-Important considerations are cost effectiveness and sustainability of the intervention(s) proposed and the ability of interventions to be widely disseminated in settings such as representative health care systems, schools, worksites, or other community settings.-Proposals should test cost effective and sustainable strategies that go beyond research settings to achieve 1) control of glycemia and other risk factors for diabetic complications, including hypertension and dyslipidemia 2) alteration in life style to prevent or reverse overweight, obesity, pre-diabetes, or type 2 diabetes in at-risk populations.-Studies submitted to this program should focus on developing preliminary data demonstrating that the proposed approach is feasible and leads to reduced body weight and or improved glycemia. The interventions proposed must have the clear potential to be applied beyond research settings and to be widely implemented in existing settings in the U.S.-Proposals focused on minorities and other high risk populations disproportionately affected by diabetes and obesity are encouraged. -Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received.-This funding opportunity will utilize the R34 mechanism. A companion announcement of identical scientific scope (PA-02-153) utilizes the Translational research project grant (R18) mechanism.-Eligible organizations: For-profit or non-profit organizations ; Public or private institutions, such as universities, colleges, hospitals; and laboratories; Units of State and local governments; Eligible agencies of the Federal government and; Faith-based or community-based organizations; Indian/Native American Tribal Government (Federally Recognized); Indian/Native American Tribal Government (Other than Federally Recognized); and Indian/Native American Tribally Designated Organization, Foreign Institutions are not eligible.-Eligible Project Directors/Principal Investigators (PDs/PIs): Any individual with the skills, knowledge, and resources necessary to carry out the proposed research is invited to work with their institution to develop an application for support. Investigators new to diabetes and obesity research are encouraged to apply. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are encouraged to apply for NIH support.-Applicants may submit more than one application, provided there is no scientific or budgetary overlap.-Eligible Project Directors/Principal Investigators (PDs/PIs): Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. -Applicants may submit more than one application, provided each application is scientifically distinct.
Wide-open applicant board · 14 Grants.gov doors
Planning Grants For Translational Research Fo… prints 14 distinct Grants.gov eligibility doors (State governments; County governments; City or township governments; Special district governments; +10 more). Filter fit before reading award size as demand — most applicant classes appear on the row. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Health (HL). Only 71 other National Institutes of Health listings share this exact eligibility-code string (1% of 12,420).
- Code 00
- State governments
- Code 01
- County governments
- Code 02
- City or township governments
- Code 04
- Special district governments
- Code 05
- Independent school districts
- Code 06
- Public / state-controlled institutions of higher education
- Code 07
- Federally recognized tribal governments
- Code 08
- Public / Indian housing authorities
- Code 11
- Native American tribal organizations (other than Federally recognized tribal governments)
- Code 12
- Nonprofits with 501(c)(3) status (other than IHEs)
- Code 13
- Nonprofits without 501(c)(3) status (other than IHEs)
- Code 20
- Private institutions of higher education
- Code 22
- For-profit organizations other than small businesses
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Parent Grant Program
Diabetes, Endocrine, and Metabolic Disease Research
National Institutes of Health
Agency Contact
NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
More from National Institutes of Health
Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)
Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)
What to do next
Planning Grants For Translational Research Fo… is closed; use the parent program and agency catalog for the next funding cycle.
- Parent CFDA 93.847 may publish future NOFOs under the same assistance listing. Open program
- Diabetes, Endocrine, and Metabolic Disease Re… indexes 72 Grants.gov listings in this extract. Program profile
- National Institutes of Health lists 12,419 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |